Sasha S. Rao is counsel in Sterne Kessler’s Trial & Appellate Practice Group. Sasha represents clients in complex patent disputes before federal district courts, the Patent Trial and Appeal Board, and the Court of Appeals for the Federal Circuit.

Sasha’s experience spans from initial fact investigation through trial, with a focus on pharmaceuticals and biologics, as well as consumer electronics, software-enabled medical devices, and chemical arts. He also counsels clients in intellectual property strategy, including licensing, infringement, validity, and freedom to operate opinions.

Sasha writes frequently on legal issues in artificial intelligence and is co-chair of the DC Bar’s AI Subcommittee.

Prior to joining the firm, Sasha was a patent litigation associate at a large IP firm and a judicial law clerk for the justices of the Massachusetts Superior Court.

Sasha performs pro bono work on indigenous IP rights and has volunteered with Engineers Without Boarders, Kids in Need of Defense, and Disability Rights Maryland.

Sasha received his J.D. from Boston University and B.S.E. in chemical engineering from Princeton University.

  • J.D., Boston University
  • B.S.E., Chemical Engineering, Princeton University

  • District of Columbia
  • Massachusetts
  • U.S. Court of Appeals for the Federal Circuit
  • United States Patent & Trademark Office

Webinar

2025 AI Intellectual Property Year in Review

Virtual, January 22, 2026 1:00 PM - 2:00 PM EST

Webinar

Trademark, Copyright, and Design—Challenges and Opportunities in the Age of AI

Virtual, July 30, 2025 1:00 PM - 2:00 PM EDT

Related News & Insights

From Sasha S. Rao

Firm News

April 29, 2026

Sterne Kessler Attorneys Recognized in 2025 Capital Pro Bono Honor Roll

Sterne, Kessler, Goldstein & Fox Multiple Authors

MarkIt to Market®

April 3, 2026

MarkIt to Market® – April 2026

Multiple Authors

Client Alert

March 27, 2026

IP Hot Topic: Think Before You Prompt – Why Your AI Chatbot Conversations May End Up in Court

Nirav N. Desai, Sasha S. Rao

Client Alert

March 9, 2026

IP Hot Topic: Cert. Denied, But One Thing is Cert-ain: The Human Authorship Requirement for Copyright

Sasha S. Rao, Ivy Clarice Estoesta

Articles

March 6, 2026

Disclosing the Undisclosable: Section 112(a) Challenges for Artificial Intelligence Patents

Westlaw Today Sasha S. Rao, Todd M. Hopfinger

Articles

January 23, 2026

AI IP Year in Review – Challenges with Protocols for Training Data Discovery in AI Litigation

Sterne, Kessler, Goldstein & Fox Sasha S. Rao, Richard A. Crudo

Articles

January 23, 2026

AI IP Year in Review – The (Media) Empire Strikes Back—An Update on Disney et al. v. Midjourney Inc.

Sterne, Kessler, Goldstein & Fox Sasha S. Rao, Ivy Clarice Estoesta

Articles

January 23, 2026

AI IP Year in Review – First Federal Ruling Rejects Fair Use Defense for AI Training Data in Copyright Dispute

Sterne, Kessler, Goldstein & Fox Sasha S. Rao, Ivy Clarice Estoesta

Articles

January 23, 2026

AI IP Year in Review – The Market Harm Dilemma: What Bartz and Kadrey Reveal About Fair Useʼs Future in Generative AI

Sterne, Kessler, Goldstein & Fox Sasha S. Rao, Ivy Clarice Estoesta

Articles

January 23, 2026

AI IP Year in Review – Patent Protection for AI Technologies: Navigating § 101 After Recentive Analytics

Sterne, Kessler, Goldstein & Fox Sasha S. Rao, Todd M. Hopfinger

Articles

January 23, 2026

AI IP Year in Review: Key Takeaways from the Federal Circuit’s First Alice Analysis for Machine Learning Patents

Sterne, Kessler, Goldstein & Fox Sasha S. Rao, Todd M. Hopfinger

Articles

January 23, 2026

AI IP Year in Review – Regulatory Update: FDA Issues Draft Guidances for AI Use in Medical Devices and for Drugs and Biologics

Sterne, Kessler, Goldstein & Fox Sasha S. Rao, Matthew S. Bodenstein

Reports

January 23, 2026

2025 AI Intellectual Property Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox Multiple Authors

Articles

November 18, 2025

Turning AI Innovation Into Patent Protection: Key Considerations

Westlaw Today Sasha S. Rao, Todd M. Hopfinger

Articles

November 5, 2025

Tariff Strategy to IP Vulnerability: How Corporate Restructuring Can Damage Patent Enforcement and Remedies

Managing IP Nirav N. Desai, Sasha S. Rao

In the News

September 19, 2025

Litigator of the Week Runners-Up and Shout-Outs

The American Lawyer Multiple Authors

Client Alert

September 17, 2025

IP Hot Topic: Vicarious Liability and AI: Alphabet’s Exit Highlights Corporate Shields

Sasha S. Rao, Ivy Clarice Estoesta

Firm News

September 16, 2025

Sterne Kessler Wins $9.5 Million Jury Verdict for Mallinckrodt Pharmaceuticals in Patent Suit

Sterne, Kessler, Goldstein & Fox Multiple Authors

MarkIt to Market®

August 29, 2025

MarkIt to Market® – August 2025

Multiple Authors

Client Alert

August 28, 2025

IP Hot Topic: From Trillion-Dollar Risk to Resolution: Settlement in the Anthropic Authors’ Class Action

Sasha S. Rao, Ivy Clarice Estoesta

Articles

August 27, 2025

Newsrooms vs. Neural Nets: How Courts Are Handling DMCA Claims Against GenAI

Westlaw Today Sasha S. Rao, Todd M. Hopfinger

U.S. IP Update

June 25, 2025

U.S. IP Update – June 2025

Multiple Authors

Client Alert

June 16, 2025

IP Hot Topic: The (Media) Empire Strikes Back

Sasha S. Rao, Ivy Clarice Estoesta

U.S. IP Update

May 20, 2025

U.S. IP Update – May 2025

Multiple Authors

Articles

April 30, 2025

Discovery of Training Data in AI Litigation

Corporate Counsel Sasha S. Rao, Richard A. Crudo

Client Alert

April 23, 2025

Federal Circuit’s First Alice-Analysis for Machine Learning Patents

Sasha S. Rao, Todd M. Hopfinger

Firm News

March 11, 2025

Sterne Kessler Secures PTAB Win for Roku in Patent Dispute with Universal Electronics

Sterne, Kessler, Goldstein & Fox Multiple Authors

MarkIt to Market®

February 27, 2025

MarkIt to Market® – February 2025

Multiple Authors

Client Alert

February 13, 2025

Fair-Use Whiplash: Thomson Reuters v. Ross Intelligence Revisits Fair Use for Artificial Intelligence

Sasha S. Rao, Ivy Clarice Estoesta

Firm News

June 20, 2024

Sterne Kessler Secures Two Federal Circuit Wins on Behalf of Client Roku

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

April 24, 2024

Sterne Kessler Secures Victory on Behalf of Teva Pharmaceuticals

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

March 25, 2024

Sterne Kessler Promotes Eight Attorneys to Counsel

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

January 25, 2024

Petition Watch: Patent Obviousness, ADA Trials, Spoofing

Law360 Multiple Authors

In the News

January 4, 2024

Victory in the courtroom: Sweegen’s Victory Redefines Stevia Sweetener

Korea IT Times Multiple Authors

Firm News

January 3, 2024

Federal Circuit Affirms Sweet Win for Sweegen in Patent Invalidity Battle

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

January 2, 2024

Fed. Circ. Backs Calif. Decision Invalidating Sweetener IP

Law360 Multiple Authors

In the News

November 7, 2023

Fed. Circ. Judge Casts Doubt On Sweetener Enzyme Patents

Law360 Multiple Authors

In the News

May 10, 2023

Sterne Kessler Represents Teva in Sleep Disorder Drug Win at Federal Circuit

Bloomberg Law Multiple Authors

In the News

March 14, 2023

Fed. Circ. Unsure Vanda’s Sleep Med Hetlioz Is Patentable

Law360 Multiple Authors

In the News

January 3, 2023

Fed. Circ. Won’t Bar Generic Sleep Meds Amid Vanda Appeal

Law360 Multiple Authors

In the News

December 13, 2022

Teva, Apotex Win Ax of Patents in Sleep Drug Suit

Law360 Multiple Authors

Firm News

June 9, 2022

Sterne Kessler and D.C. Bar Pro Bono Center Host Sixth Annual Small Business Clinic

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

May 25, 2022

Tastes Like Invalidity—Judge Knocks Out Sweetener Patents, Despite PTAB Ruling

The Recorder Multiple Authors

Firm News

May 25, 2022

Sterne Kessler Team Secures Summary Judgment of Patent Invalidity on Behalf of Sweegen, Inc. in District Court

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

May 24, 2022

Stevia Patent Claims Fall After Sweegen Challenge

Law360 Multiple Authors

In the News

May 24, 2022

Sweegen Wins Challenges to Rival’s Artificial Sweetener Patents

Bloomberg Law Multiple Authors

IP Strategies and Insights

November 18, 2020

PTAB Strategies and Insights – November 2020

Jason D. Eisenberg, Sasha S. Rao

Articles

November 18, 2020

Missing Analysis of “Problem Being Solved” Dooms PTAB Non-Analogous Art Findings and Court Orders a Redo on Remand

Sterne, Kessler, Goldstein & Fox Jason D. Eisenberg, Sasha S. Rao

In the News

June 23, 2020

Obviousness Doomed Narcan Patents After NJ Bench Trial

Law360 Multiple Authors

In the News

June 5, 2020

Teva Invalidates Opiant Patents In Narcan Suit

Law360 Multiple Authors